These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma.
    Author: Bataille R, Grenier J, Sany J.
    Journal: Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602.
    Abstract:
    Measuring serum beta-2-microglobulin (B2M) in 90 patients with multiple myeloma (MM) from diagnosis to death (83 cases), or to the terminal phase of their disease (7 cases), we have obtained evidence that 9% of them retained normal serum B2M levels during the whole of their follow-up. This was observed in 6 IgA MM, in one light chain MM only and in one non-secretory MM. These data suggest a lack of B2M production and/or secretion by some myeloma tumors. This could limit the use of B2M as clinical marker in MM.
    [Abstract] [Full Text] [Related] [New Search]